Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NCT02176564
NCT02176564CompletedNot Applicable

COPD, Inhaled Bronchodilators Association, and Quality of Life

Boehringer Ingelheim0 sites2,639 target enrollmentStarted: June 1999Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
2,639
Primary Endpoint
Assessment of health-related quality of life (Short-Form Health Survey)
Study OverviewStudy DesignEligibility CriteriaArms & InterventionsOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

A pharmaco-epidemiological, observational study that aimed at assessing in a prospective manner the evolution of Quality of Life (QOL) in chronic obstructive pulmonary disease (COPD) patients treated with inhaled bronchodilators

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Diagnosis of COPD confirmed by Pulmonary Function Test (PFTs)
  • •Recent treatment with a free or fixed association of inhaled bronchodilators

Exclusion Criteria

  • Not provided

Arms & Interventions

Chronic obstructive pulmonary disease

Patients with COPD treated with inhaled bronchodilators

Intervention: inhaled bronchodilator (Drug)

Outcomes

Primary Outcomes

Assessment of health-related quality of life (Short-Form Health Survey)

Time Frame: 4 months

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Similar Trials

Withdrawn
Not Applicable
A Prospective, Observational Study of COPD Patients in U.S. HospitalsChronic Obstructive Pulmonary Disease
NCT02406534EPI-Q
Completed
Phase 3
Study in Patients With COPDCOPD
NCT00215449Dey690
Recruiting
Not Applicable
Prospective observational Study for the COPD exacerbatioChronic obstrucive pulmonary disease
JPRN-UMIN000005947Deoartment of Respiratory Medicine, Kyoto university300
Terminated
Phase 2
A Single-dose Study to Investigate the Effects of 4 Different Doses of Inhaled AZD8683 in Chronic Obstructive Pulmonary Disease (COPD) PatientsCOPDChronic Obstructive Pulmonary Disease
NCT01708057AstraZeneca3
Unknown
Not Applicable
A Multi-center Study to Determine the Prevalence and Influence of Pertussis on Subacute Cough in ShenzhenChronic CoughPertussis
NCT04694963Shenzhen People's Hospital500